The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

The Possibility for Immunotherapy in Neoadjuvant Bladder Cancer Treatment

Geoffrey Sklar, MD
Published Online:3:02 PM, Mon January 9, 2017

Geoffrey Sklar, MD, Chief Medical Officer, Chesapeake Urology Associates, discusses the possibility for immunotherapy as a neoadjuvant treatment in bladder cancer.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.